万维提示：
1、投稿方式：官网投稿。
2、期刊网址：
https://www.ametsoc.org/index.cfm/ams/publications/journals/journal-of-climate/
3、投稿网址：
https://jtd.amegroups.com/author/submit
4、官网邮箱：
jtd@amepc.org（编辑部）
permissions@amegroups.com（版权相关联系人）
sales@amegroups.com（商业销售联系人）
5、期刊刊期：月刊，一年出版12期。
2022年01月11日星期二
投稿须知【官网信息】
JOURNAL OF THORACIC DISEASE
Thank you for your interest in the Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624). JTD adheres to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals, issued by the International Committee of Medical Journal Editors (ICMJE) (1), and the Cope of Conduct and Best Practice Guidelines for Journal Editors (2), issued by the Committee on Publication Ethics (COPE). Please refer to the following guidelines to help you prepare your manuscript. Feel free to contact the editorial office by email (jtd@amepc.org). should you have any questions. To ensure a swift peer review and publication process, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision at preliminary review.
1. ABOUT THE JOURNAL
The Journal of Thoracic Disease was founded in December 2009, and indexed on PubMed in December 2011 and the Science Citation Index Expanded (SCIE) in February 2013. It was first published quarterly (between December 2009 and December 2011), then bimonthly (between January 2012 and December 2013), and since January 2014, has been published monthly. With a worldwide distribution, JTD publishes manuscripts that shine a light on new findings in the field of thoracic disease, providing current and practical information on the diagnosis and treatment of conditions including lung disease, cardiovascular disease, and esophageal disease. All submissions and reviews are conducted electronically so that a swift process is assured.
JTD is the Official Publication of the China State Key Laboratory of Respiratory Disease, the Guangzhou Institute of Respiratory Health (GIRH), the First Affiliated Hospital of Guangzhou Medical University and the Society of Translational Medicine (STM).
2. MANUSCRIPT CATEGORIES
2.1 Original Article
Word limit: there is no fixed word limit for research articles, but authors must use the most concise language possible, as well as succinct, structured sentences. The word count for the main text (excluding the abstract, references, tables, boxes, or figures) should be provided when the manuscript is submitted.
Abstract: Structured (usually into four paragraphs with the following subheadings: Background, Methods, Results, and Conclusions, unless specified otherwise in the reporting checklists), 200-350 words max. No abbreviations.
Key words: 3~5.
References: No limit.
Figures/Tables: No limit, but 10 figures are deemed sufficient.
Description: Original articles should take the following format: Introduction, Methods, Results, Discussion and/or Conclusions. Original articles must have originality and clinical impact.
Original articles should include a section describing the contribution made by each author to the manuscript as well as an ethical statement. See the “3.4 Author Contributions” sections for details.
If a submitted article includes any data that are not publicly available, the authors are required to fill in a data-sharing statement form, which should be submitted along with their manuscript. If the article is accepted for publication, the Data Availability Statement (form) will be published online alongside the article. See the “3.7.2 Data Sharing Statement” section for details.
When a manuscript documents any experiment(s) involving human subjects or animals, the authors must indicate an ethical statement both in the methods section and the footnote. See the “3.7.5 Ethical Statement” section for details.
Please note that systematic review with meta-analysis will be categorized as Original Article.
2.1.1 Reporting Checklist
Original Articles should be prepared according to the EQUATOR research reporting guidelines, as listed below, and each submission should include a checklist (a reformatted version has been created for the journal) as a supplementary material. The relevant page/line and section/paragraph number in the manuscript should be stated for each item in the checklist. A statement should be included at the end of the “Introduction” to indicate which reporting checklist was followed (e.g., “We present the following article/case in accordance with the CONSORT reporting checklist.”). The manuscript should also include a Reporting Checklist statement in the footnote (see the “3.7 Footnote” section). Failure to do so will result in the manuscript being returned to the authors for amendment.
2.1.2 Selection And Description Of Participants
In study articles, the process of selection for observational or experimental subjects (healthy individuals or patients, including controls) should be clearly set out in the methods section. Any eligibility or exclusion criteria should be provided, along with a description of the population from which the subjects were sourced. Ideally, representative populations should be included in all study types and characteristics (such as age, sex, or ethnicity) of the study population should be described. Terms relating to sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors) should be used correctly, and the sex and/or gender of the human participants, or the sex of animals or cells, should be reported, except where this is not appropriate. The methods used to classify sex and gender should also be described, where relevant. If the study focused on a specific population (e.g., only females), unless the reason is obvious (e.g., cervical cancer), the authors should explain their reasoning for this. For race and ethnicity, authors should describe how these were determined, and their relevance to the study should be explained. Study subjects should be described in the most neutral, exact, and respectful language possible. Any language that might cause the stigmatization of subjects must be avoided.
2.1.3 Research Resource Identifiers (RRID)
JTD is pleased to be a part of the Research Resource Identification Initiative, a project aimed at clearly identifying key research resources, aka materials, used in the course of scientific experiments. These include antibodies, cell lines, model organisms, and software tools. To help authors quickly find the correct identifiers for their materials there is a single web site (https://scicrunch.org/resources) where all resource types can be found and a 'cite this' button next to each resource that contains proper citation text that should be included in the methods section of the manuscript. Several examples of properly formatted methods sections with RRIDs can be found below:
……
更多详情：
https://jtd.amegroups.com/pages/view/guidelines-for-authors
